A pilot, open‐label, 8‐week study evaluating the efficacy, safety and tolerability of adjunctive minocycline for the treatment of bipolar I/II depression - Concepedia

Concepedia

Publication | Closed Access

A pilot, open‐label, 8‐week study evaluating the efficacy, safety and tolerability of adjunctive minocycline for the treatment of bipolar I/II depression

48

Citations

109

References

2017

Year

Joanna K. Soczynska, Sidney H. Kennedy, Mohammad Alsuwaidan, Rodrigo B. Mansur, Madeline Li, Mary Pat McAndrews, Elisa Brietzke, Hanna O. Woldeyohannes, Valerie H. Taylor, Roger S. McIntyre

Bipolar Disorders

Abstract

Results from the pilot study suggest that adjunctive minocycline may exert antidepressant effects in individuals with bipolar depression, possibly by targeting inflammatory cytokines.

References

	Year	Citations

Page 1